COMMUNIQUÉS West-GlobeNewswire

-
Major shareholder announcement
02/10/2019 -
DLT Telecom Launches North American-Wide Agent Program
02/10/2019 -
Minneapolis Company Circadian Optics to Appear on TV’s Shark Tank
02/10/2019 -
Skyline Medical, a Division of Predictive Oncology Inc. (POAI), Sells 10 STREAMWAY® Systems to Prominent Teaching Hospital
02/10/2019 -
Blood Clot Risk among People with Cancer
02/10/2019 -
Nextech to Showcase Latest Ophthalmology Innovations at the American Academy of Ophthalmology Annual Meeting
02/10/2019 -
Revenue Cycle Solutions Leader Alltran Health Joins Meduit to Form One of the Largest RCM Companies in the Nation
02/10/2019 -
Capricor to Present Interim Results from the HOPE-2 Trial in a Late Breaking Session of the World Muscle Society and Company to Host Conference Call Monday, October 7 at 5:30 AM PT / 8:30 AM ET
02/10/2019 -
Envision Mind Care Now Offering Mental Health Technology for Patients with Major Depressive Disorder (MDD) in Edmonton, Alberta
02/10/2019 -
AI-enabled prescriptive analytics leader Jvion Named to the 2019 CB Insights Digital Health 150 -- List of Most Innovative Digital Health Companies
02/10/2019 -
Rafael Pharmaceuticals Appoints Wendy McDermott to Chief People Officer
02/10/2019 -
Arcturus Therapeutics to Present at Three Upcoming Investor Conferences
02/10/2019 -
New U.S. Department of Defense Research Collaboration with Immuron to Develop and Clinically evaluate a New Therapeutic against Campylobacter
02/10/2019 -
Former NY Yankees Outfielder Chris Dickerson Teams Up With Flexion Therapeutics to Raise Awareness of Impact of Osteoarthritis (OA)
02/10/2019 -
XBiotech Announces First Patient in Clinical Study to Evaluate Bermekimab in Systemic Sclerosis
02/10/2019 -
Eyenovia to Participate in Multiple Upcoming Medical Meetings
02/10/2019 -
Ultragenyx to Present at Jefferies Gene Therapy/Editing Summit
02/10/2019 -
CellaVision completes the acquisition of RAL Diagnostics
02/10/2019 -
Predictive Oncology Inc. Announces Pricing of Public Offering of Up to $3,167,768.50 of Common Stock
02/10/2019
Pages